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Background: Methadone treatment was introduced in Taiwan in 2006 as a harm-reduction program for injection
drug users (IDUs), among whom HIV was endemic. We examined the association of HIV serostatus with demographic
characteristics, substance use, and sexual behaviors among IDUs at methadone clinics in Taipei, Taiwan.
Methods: During 2012–2013, IDUs at methadone clinics in Taipei were recruited to complete a risk assessment
interview and undergo serologic testing for HIV infection. Correlates of HIV infection were identified by multivariate
logistic regression.
Results: Of the 827 eligible participants, 85.9% were male, median age was 45 years, and mean years of injecting was
18.0 (range 1–56). The prevalence of HIV infection was 17.7%. In multivariate analysis, HIV infection was significantly
associated with age ≤45 years (adjusted odds ratio [AOR] = 1.62, 95% confidence interval [CI] 1.01–2.62), being divorced
(AOR = 1.67, 95% CI 1.06–2.62), deriving the majority of income during the previous 6 months from temporary jobs or
other noncriminal sources (AOR = 1.53, 95% CI 1.02–2.30), unstable housing during the previous 6 months (AOR = 1.47,
95% CI 1.003–2.15), higher number of incarcerations (AOR = 1.14, 95% CI 1.03–1.26), and a history of overdose
(AOR = 1.51, 95% CI 1.01–2.28).
Conclusions: Taiwanese IDUs at methadone clinics have a relatively high HIV prevalence, which was associated
with younger age and history of overdose. It is imperative to educate IDUs’ about HIV transmission, particularly for
the younger and overdosed IDUs.
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Injection drug users (IDUs) are susceptible to blood-
borne infectious diseases such as human immunode-
ficiency virus (HIV) infection. In 2008, there were an
estimated 15.9 million IDUs globally, of whom 18.9%
were infected with HIV [1]. In Asia in the same year, HIV
prevalence among IDUs was approximately 16.0% overall
(range 1.0% to 42.6%) [1]. IDUs have poor adherence to
HIV screening and treatment [2], which complicates HIV
control. It is therefore vital to investigate factors associated
with HIV infection among IDUs in order to help design* Correspondence: cydeng@ym.edu.tw
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reproduction in any medium, provided the ormeasures that are effective in curtailing HIV spread among
this vulnerable population.
In Taiwan, HIV infection was first identified in a male
foreigner in 1984 and later among homosexuals, hetero-
sexuals, IDUs, pregnant women, those receiving blood
transfusions, and hemophilia patients requiring infusion
of clotting factor [3]. The Taiwan Department of Health
has provided HIV-infected persons with free antire-
troviral therapy since 1997 [4]. The number of newly
reported HIV/AIDS cases continued to increase rap-
idly every year: from 860 cases in 2003 to 1520 cases in
2004 to 3380 cases in 2005. The percentage of these
cases attributed to IDUs also increased markedly, from
9.3% in 2003 to 40.9% in 2004 to 71.6% in 2005 [3]. To
curb this surge in HIV among IDUs, the Taiwan Centers
for Disease Control (CDC) began a harm reduction. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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for IDUs and methadone therapy for heroin addicts. At the
end of 2012, the number and percentage of newly reported
HIV cases attributable to IDUs had decreased significantly,
to 81 cases and 3.6%, respectively. Presently in Taiwan,
IDUs are the second most frequent source of HIV infec-
tion, accounting for 27.6% of all reported HIV cases [3].
IDUs are socially marginalized people and are hard to
reach in the community. Studies that attempted to re-
cruit IDUs from one or more treatment or correctional
centers were able to enroll only a limited number of re-
search subjects or HIV-positive cases [5-8]. Recently,
two studies that analyzed HIV surveillance data might
have underestimated HIV prevalence among IDUs, be-
cause information on HIV status was collected many
months or years before the subjects entered into correc-
tional institutions or methadone programs [9,10]. An-
other study of IDUs, which did not use Western blot to
confirm HIV status, might have overdiagnosed the con-
dition [11]. Moreover, few studies have addressed the as-
sociation between drug overdose and HIV infection
among IDUs. One study reported that IDUs with a his-
tory of drug overdose were more likely to have risky sex-
ual behaviors [12], which increase the risk of HIV
infection. Evidence on transmission risks can help guide
interventions for HIV prevention. Therefore, we esti-
mated HIV prevalence and attempted to identify factors
associated with HIV infection among IDUs recruited at
community-based methadone clinics in Taipei, Taiwan.
Methods
Study population and eligibility
This cross-sectional study consecutively recruited IDUs
from Taipei City Hospital (TCH) methadone clinics from
March 2012 to April 2013. The clinics were established in
2007 and now serve approximately 90.6% of methadone
clients in Taipei [3]. All the clients are IDUs with a history
of heroin addiction and are voluntarily enrolled in the pro-
gram [3]. Each day they are required to report to metha-
done stands to receive free methadone therapy under
direct supervision; those who fail to do so for 2 weeks
or longer are removed from the therapy list. Our study
included methadone clients who were 18 years of age or
older, had a history of injecting illicit drugs, and had given
written informed consent. Clients with severe cognitive
deficits were excluded from this study. Study participants
who completed the survey were compensated with 300
New Taiwan Dollars (equivalent of US$10) for their time.
This study was approved by the Institutional Review Board
of TCH (Approval number: TCHIRB-1000903).
Data collection
At the time of study enrollment, consenting participants
completed a face-to-face interview administered by trainedcase managers using a standardized questionnaire. The
average duration of the interview was about 50 minutes.
The case managers maintain a good rapport with
participants, provide them with methadone therapy,
monitor their treatment complications daily, and pro-
mote treatment adherence. The questionnaire was
used to collect information on participant sociode-
mographics, substance use and injection practices,
and sexual behaviors. Sociodemographic characteris-
tics included age, gender, marital status, education
completed, principal source of income during the pre-
vious 6 months, housing status during the previous
6 months, history of methadone treatment, and history
and frequency of incarceration. Marital status was clas-
sified as unmarried, married, divorced, and widowed,
and the categories for education level were elementary
school or below and high school and above. Principal
source of income during the previous 6 months was
categorized as (1) regular work (defined as a full-time
job; used as the reference category in statistical ana-
lysis), (2) temporary work or other noncriminal sources
(ie, informal or temporary work, panhandling, social
assistance, and financial support from families or
friends), and (3) illegal sources (ie, theft, robbery, sell-
ing drugs, operating a drug injection site, and trading
sex for money). Housing status was assessed by asking
participants about the place in which they slept most
often during the prior 6 months and was grouped into
two broad categories: (1) stable housing (ie, living in
their own house or apartment or that of their family,
partner, or friend—the reference category) and (2) un-
stable housing (ie, living in workplaces, rented rooms,
cars or other vehicles, abandoned buildings, shelters or
welfare residences, jails, streets, or medical care organi-
zations. The present participants included IDUs who
were receiving methadone treatment and those who
were seeking methadone therapy for the first time.
History of methadone treatment was thus categorized
as never, once, and twice or more.
Substance use and injection practices included age at
first use of drugs, number of years of injecting, syringe
and diluted water sharing during the previous 3 months,
history of drug overdose (worded as “By drug overdose
we mean taking enough drugs to stop your breathing or
heartbeat”), history of cutaneous abscesses, and any
alcohol use during the previous 3 months. The effect of
police interference in drug use was investigated by ask-
ing participants, “How fearful are you that the police are
going to arrest you or interfere with your drug use?”.
The possible responses to this question were “not at all”,
“somewhat”, and “very”. Sexual behaviors included age at
sexual debut, ever giving someone money or drugs in
exchange for sex, and history of sexually transmitted
infection (STI).
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After the above interview, all participants had their
blood drawn for HIV testing. HIV antibody testing was
performed at the Kun-Ming Laboratory (Taipei, Taiwan)
and consisted of an enzyme-linked immunosorbent assay
(Genscreen HIV1/2 version 2) followed by Western blot
confirmation of reactive samples, according to standard
protocols [13].
Statistical analysis
In bivariate analysis, variables were analyzed using means
or medians for continuous measures and frequencies and
percentages for categorical variables. The chi-square
test was used to assess bivariate associations of selected
factors with HIV infection. Multiple logistic regression
analysis was used to estimate adjusted odds ratios
(AORs) and their 95% confidence intervals (CIs) after
controlling for other covariates. Analyses were con-
ducted using the SPSS version 21.0 statistical software
package (SPSS, Chicago IL, USA).
Results
Of the 831 IDUs enrolled at the methadone program
during the study period, 99.5% (827) completed both the
interview and blood testing and were thus included in
the subsequent analysis. Overall, the prevalence of HIV
was 17.7% (95% CI 15.1–20.3%). The median age of the
study subjects was 45 years (interquartile range 38–52
years); 85.9% were male; and the mean duration of injec-
tion drug use was 18.0 years (range 1–56 years).
In bivariate analysis, HIV-positive IDUs were more
likely than HIV-negative IDUs to be aged ≤45 years, to
be divorced, to have received most of their income from
temporary jobs or other noncriminal sources during the
previous 6 months (reference: regular jobs), and to have
had more incarcerations (mean 3.0 vs. 2.6; p = 0.043)
(Table 1). In terms of substance use and sexual behav-
iors, HIV-positive IDUs were more likely to have histor-
ies of overdose and STIs.
Multiple logistic regression analysis showed that,
after controlling for covariates, HIV infection was sig-
nificantly associated with age ≤45 years (AOR = 1.62,
95% CI 1.01–2.62), being divorced (AOR = 1.67, 95% CI
1.06–2.62), deriving the majority of income from tempor-
ary jobs or other noncriminal sources during the previous
6 months (AOR = 1.53, 95% CI 1.02–2.30), unstable hous-
ing during the previous 6 months (AOR = 1.47, 95% CI
1.003–2.15), a higher number of incarcerations (AOR per
incarceration =1.14, 95% CI 1.03–1.26), and a history of
overdose (AOR = 1.51, 95% CI 1.01–2.28) (Table 2).
Discussion
Our analysis showed that the prevalence of HIV infec-
tion was 17.7% among IDUs at methadone clinics inTaipei during 2012–2013. After controlling for other
characteristics, factors significantly associated with HIV
infection were aged ≤45 years, being divorced, deriving
the majority of income during the previous 6 months
from temporary jobs or other noncriminal sources,
unstable housing during the previous 6 months, a higher
number of incarcerations, and a history of overdose.
As compared with IDUs at methadone programs in
other Asian countries, HIV prevalence among IDUs was
higher in Taipei than the 6% reported in China [14] but
lower than the 35.9% reported in Thailand [11]. The
high prevalence of HIV infection among IDUs in these
countries is a serious public health problem that de-
serves increased attention. In 2006 the Taiwan CDC
began a harm reduction program in response to a then
rapidly growing HIV epidemic among IDUs. Currently
there are 94 methadone clinics nationwide offering
substitution treatment and clean syringes to IDUs (4).
Consequently, estimated HIV incidence among IDUs
in Taiwan decreased from 3.03/100 person-years at risk
(PYAR) in 2005 to 0.93/100 PYAR in 2007 to 0.10/100
PYAR in 2012 (4).
In a comparison with previous findings on IDUs in
Taiwan, HIV prevalence was higher in this study than
the 12% noted among methadone clients in northern
Taiwan in 2008 [9]. Also, 17.3% of male IDUs were HIV-
positive in this study, which was lower than the rate of
25.5% among incarcerated male IDUs in 2005 [8]. The
high prevalence of HIV among Taiwanese IDUs might
be due to a change from smoked to injected heroin,
which occurred during the most recent decade, [15]
and/or to an increase in the frequency of HIV-associated
risk behaviors such as needle sharing [10,16,17].
This study found that IDUs with a history of STIs
had a higher prevalence of HIV infection than those
without (23.6% vs. 16.4%). Furthermore, a history of
overdose was associated with HIV infection in this
study, after controlling for potential confounders. Pre-
vious study showed that IDUs with a history of over-
dose were more often involved in high-risk situations
such as sex work [12], which might increase the risky
behavior of unprotected sex. Since there is neither a
cure nor a vaccine against HIV/AIDS, educating IDUs’
about HIV transmission and reducing their high-risk
behaviors provide an important protection against the
infection concerned [18,19].
This study also found that an age of ≤45 years was
associated with HIV infection, which suggests that
younger IDUs are involved in risky social networks
[20] and thus more HIV-associated risk behaviors
[21,22]. They also tend to lack knowledge of HIV infec-
tion [23], which could increase their risk of infection.
Because the interventions that target the IDUs at high-
est risk are the most cost-effective measures [24],
Table 1 Bivariate analysis of factors associated with HIV seropositivity among injection drug users at the methadone
clinics in Taipei, Taiwan
Factors HIV (-) (n = 681) HIV (+) (n = 146) p value OR (95% CI)
Sociodemographics
Age (years)
18-45 349 (79.9) 88 (20.1) 0.047 1
>45 332 (85.1) 58 (14.9) 0.69 (0.48-0.99)
Gender
Female 94 (80.3) 23 (19.7) 0.54 1
Male 587 (82.7) 123 (17.3) 0.86 (0.52-1.41)
Marital status
Unmarried 333 (83.5) 66 (16.5) 0.024 1
Married 180 (87.0) 27 (13.0) 0.76 (0.47-1.23)
Divorce 159 (76.1) 50 (23.9) 1.59 (1.05-2.40)
Widowed 9 (75.0) 3 (25.0) 1.69 (0.44-6.38)
Education level completed
≤Elementary school 110 (85.9) 18 (14.1) 0.246 1
High school and above 571 (81.7) 128 (18.3) 1.37 (0.80-2.34)
Source of most income during last 6 months
Regular job 384 (85.3) 66 (14.7) 0.108 1
Temporal jobs or other legal source 270 (79.2) 71 (20.8) 1.53 (1.06-2.21)
Illegal source 27 (75.0) 9 (25.0) 1.94 (0.87-4.31)
Housing status during last 6 months
Stable housing 434 (84.1) 82 (15.9) 0.087 1
Unstable housing 247 (79.4) 64 (20.6) 1.37 (0.96-1.97)
History of methadone treatment
Never 49 (87.5) 7 (12.5) 0.143 1
Once 219 (85.2) 38 (14.8) 1.22 (0.51-2.88)
Twice or more 413 (80.4) 101 (19.6) 1.71 (0.75-3.89)
Number of incarceration
Mean (range) 2.6 (0,10) 3.0 (0, 12) 0.043 1.09 (1.003-1.19)
Substance use and injection practices
Age at first injection drug use (years)
<20 93 (83.0) 19 (17.0) 0.837 1
≥20 588 (82.2) 127 (17.8) 1.06 (0.62-1.80)
Duration of drug use (years), mean (sd) 18.2 (10.4) 16.9 (8.0) 0.148 0.99 (0.97-1.01)
Shared syringes during last 3 months
No 649 (82.2) 141 (17.8) 0.499 1
Yes 32 (86.5) 5 (13.5) 0.72 (0.28-1.88)
Shared diluted water during last 3 months
No 633 (82.4) 135 (17.6) 0.836 1
Yes 48 (81.4) 11 (18.6) 1.08 (0.54-2.12)
History of drug overdose
No 498 (84.7) 90 (15.3) 0.005 1
Yes 183 (76.6) 56 (23.4) 1.69 (1.17-2.46)
History of cutaneous abscess
No 591 (83.0) 121 (17.0) 0.216 1
Yes 90 (78.3) 25 (21.7) 1.36 (0.84-2.20)
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Table 1 Bivariate analysis of factors associated with HIV seropositivity among injection drug users at the methadone
clinics in Taipei, Taiwan (Continued)
Any alcohol during last 3 months
No 532 (83.0) 109 (17.0) 0.363 1
Yes 149 (80.1) 37 (19.9) 1.21 (0.80-1.84)
Very fearful of police interference during drug use
No 288 (85.0) 51 (15.0) 0.101 1
Yes 393 (80.5) 95 (19.5) 1.37 (0.94-1.98)
Sexual behaviors
Age at sexual debut (years)
<16 122 (83.0) 25 (17.0) 0.820 1
≥16 559 (82.2) 121 (17.8) 1.06 (0.66-1.70)
Ever giving someone money in exchange for sex
No 575 (81.8) 128 (18.2) 0.567 1
Yes 105 (85.4) 18 (14.6) 0.77 (0.45-1.32)
Unknown 1 (100.0) 0 (-)
History of sexually-transmitted infections
No 574 (83.6) 113 (16.4) 0.044 1
Yes 107 (76.4) 33 (23.6) 1.57 (1.01-2.43)
Key: HIV = human immunodeficiency virus, OR = odds ratio, CI = confidence interval, STI = sexually transmitted infection.
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and education.
HIV prevalence was higher among IDUs with a greater
number of incarcerations. Prior studies found that this
IDU subgroup more often participated in injecting
behaviors associated with HIV infection [25,26]. InTable 2 Multivariate logistic regression analysis of factors
associated with HIV seropositivity among injection drug
users at methadone clinics in Taipei, Taiwan1
Factors AOR 95% CI






Source of most income in last 6 months
Regular job 1
Temporal jobs or other legal source 1.59 1.05-2.39
Illegal source 1.65 0.70-3.87
Unstable housing in last 6 months 1.47 1.003-2.15
Number of incarceration (per time increase) 1.14 1.03-1.27
History of drug overdose 1.54 1.02-2.32
1after controlling for subject sociodemographics, substance use, and
sexual behaviors.
Key: HIV = human immunodeficiency virus, AOR = adjusted odds ratio,
CI = confidence interval.addition, a cohort study in Taiwan showed that more
than 40% of IDUs began using drugs again within
1.5 years after release from a correctional setting [27]. To
better control the HIV epidemic among IDUs, incarcer-
ated IDUs should receive education about HIV infection
and, once released, should be strongly encouraged to
refrain from drug use (eg, through harm reduction pro-
grams) [28].
Although not significant in the multivariable model,
58.5% of participants reported that they were “very” fear-
ful of police interference in their drug use. Two qualita-
tive studies showed that IDUs who perceive a threat of
police interference during drug use will forgo safe injec-
tion practices to avoid unwanted interactions with police
[29,30]. Further studies should assess the impact of
policing on IDU injection practices.
As in prior studies, being divorced [31] and unstable
housing [32] were associated with HIV infection.
The results of this study should be interpreted in the
light of certain limitations. First, it is difficult to estab-
lish temporal sequences between factors investigated in
cross-sectional research. Indeed, it is more difficult to
do so in this study because HIV-positive patients often
do not know exactly when they were infected and because
we have no information on the HIV status of study sub-
jects before their participation in this study. However, the
HIV status of the participants was evaluated by laboratory
testing rather than by self-report. Those found to be
HIV-positive were referred to HIV specialists for fur-
ther evaluation and treatment. Second, information
Yen et al. BMC Public Health 2014, 14:682 Page 6 of 7
http://www.biomedcentral.com/1471-2458/14/682bias regarding risk behaviors cannot be avoided by
using a self-reported questionnaire. We reduced this
bias by having the interviews conducted by the case
managers—that is to say, the same people who pro-
vided the study subjects with methadone treatment and
psychological support. Third, it is difficult to obtain a truly
representative sample of a population of community-
dwelling IDUs. It was estimated that methadone clients
accounted for 10.8% of reported heroin-addicted drug
users in Taipei in 2012 [33]. Thus, the generalizability of
the present findings might be limited to IDUs at Taipei
methadone clinics.
Conclusions
In conclusion, Taiwanese IDUs at methadone clinics had
a relatively high HIV prevalence, which was associated
with younger age and history of overdose. It is impera-
tive to educate IDUs’ about HIV transmission, particu-
larly for the younger and overdosed IDUs.
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